| Overall survival | ||
---|---|---|---|
Variables | HR | 95% CI | P value |
Univariate analysis | |||
Age (y, ≤ 60/ > 60) | 3.385 | 1.829–2.264 |  < 0.001*** |
Gender | 1.197 | 0.662–1.162 | 0.552 |
AFP (ng/ml, ≤ 20/ > 20) | 2.378 | 1.334–4.238 | 0.003** |
Cirrhosis | 2.906 | 1.608–5.251 |  < 0.001*** |
HBV | 1.132 | 0.512–2.502 | 0.760 |
Tumor size (cm, ≤ 5/ > 5) | 2.998 | 1.596–5.633 | 0.001** |
Pathological stage | 0.309 | 0.167–0.570 |  < 0.001*** |
Intrahepatic metastasis | 2.942 | 0.867–9.984 | 0.084 |
STAG3 expression | 0.114 | 0.048–0.272 |  < 0.001*** |
Multivariate analysis | |||
Age (y, ≤ 60/ > 60) | 1.994 | 0.972–4.090 | 0.060 |
AFP (ng/mL, ≤ 20/ > 20) | 1.000 | 0.516–1.940 | 1.000 |
Cirrhosis | 1.398 | 0.670–2.916 | 0.372 |
Tumor size (cm, ≤ 5/ > 5) | 1.025 | 0.511–2.055 | 0.944 |
Pathological stage | 0.394 | 0.195–0.797 | 0.010* |
STAG3 expression | 0.174 | 0.063–0.483 | 0.001** |